$18.22

+0.10 (+0.55%)

Weekly Expected Move ±2.9%

$17 $18 $18 $19 $19

NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 41 · $5.2B mcap · 154M float · 1.68% daily turnover · Short 63% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$1.2B +5.7% ▲

5Y CAGR: +7.3%

Gross Profit

$646M +7.2% ▲

5Y CAGR: +7.8%

Operating Income

$393M +32.0% ▲

5Y CAGR: +13.8%

Net Income

$78M +75.6% ▲

EPS (Diluted)

$0.27 +68.8% ▲

EBITDA

$303M -31.4% ▼

5Y CAGR: -1.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$931M	$1.0B	$1.0B	$1.1B	$1.2B
YoY Growth	+13.9%	+7.8%	+4.5%	+4.9%	+5.7%
Cost of Revenue	$413M	$447M	$472M	$498M	$518M
Gross Profit	$519M	$557M	$577M	$602M	$646M
Gross Margin	55.7%	55.5%	55.0%	54.7%	55.5%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$198M	$246M	$237M	$243M	$253M
Operating Expenses	$262M	$309M	$300M	$305M	$253M
Operating Income	$257M	$248M	$277M	$298M	$393M
Operating Margin	27.6%	24.7%	26.4%	27.0%	33.8%
Interest Expense	$74M	$80M	$143M	$165M	$156M
Income Before Tax	$176M	-$243M	$106M	$114M	$148M
Tax Expense	$59M	-$10M	$55M	$69M	$70M
Net Income	$117M	-$234M	$51M	$44M	$78M
Net Margin	12.5%	-23.3%	4.9%	4.0%	6.7%
EPS (Diluted)	$0.41	$-0.83	$0.18	$0.16	$0.27
EBITDA	$401M	-$17M	$407M	$442M	$303M
Shares Outstanding	279M	280M	283M	285M	286M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$285M	$290M	$255M	$294M	$311M	$303M	$280M	$321M
Cost of Revenue	$127M	$126M	$119M	$128M	$134M	$138M	$136M	$143M
Gross Profit	$158M	$164M	$135M	$167M	$178M	$166M	$144M	$178M
Gross Margin	55.4%	56.6%	53.2%	56.6%	57.0%	54.7%	51.4%	55.4%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$62M	$62M	$63M	$69M	$63M	$58M	$57M	$68M
Operating Expenses	$78M	$77M	$78M	$78M	$66M	$30M	$57M	$71M
Operating Income	$81M	$87M	$57M	$88M	$111M	$136M	$87M	$107M
Operating Margin	28.2%	30.0%	22.4%	30.0%	35.7%	44.9%	30.9%	33.2%
Interest Expense	$42M	$41M	$41M	$41M	$39M	$35M	$35M	$34M
Income Before Tax	$43M	$45M	-$15M	$19M	$73M	$70M	$43M	$78M
Tax Expense	$26M	$33M	-$2M	$11M	$25M	$36M	$16M	$24M
Net Income	$17M	$12M	-$13M	$8M	$48M	$35M	$27M	$54M
Net Margin	6.0%	4.2%	-5.2%	2.7%	15.5%	11.5%	9.5%	16.7%
EPS (Diluted)	$0.06	$0.04	$-0.05	$0.03	$0.17	$0.12	$0.09	$0.19
EBITDA	$127M	$126M	$67M	$95M	$138M	$146M	$109M	$146M
Shares Outstanding	286M	285M	284M	286M	287M	286M	288M	288M

SHC NASDAQ